Advancing viral vector manufacturing with innovation: the importance of the cell line

Marguerite Campbell is an experienced cell and molecular biologist with over 25 years of experience in the biotech and pharmaceutical industries, and national labs. In her current role at SK pharmteco, she leads the Upstream Processing team and has played an integral role in the cell line development efforts for viral vector manufacturing. Previously, she was a Senior Scientist at Janssen Pharmaceuticals in the Cell Line Development group which supported the biotherapeutic pipeline for 15+ years, a Scientist at Exelixis focusing on bacterial and baculovirus expression systems, and a Biomedical Researcher at the Joint Genome Institute. She received her MS in Molecular Biology from Temple University.

Brian is an accomplished cell and molecular biologist with 15+ years of experience in the biotech and pharmaceutical industries. His career is dedicated to the discovery, development, and delivery of curative cell and gene therapies for human diseases. Currently, he is the Senior Director, Head of Research & Development at SK pharmteco where his research focus is on cell development and viral vector engineering to improve viral vector manufacturing. Prior to SK pharmteco, he was a Senior Principal Investigator at Janssen Pharmaceuticals where he led efforts to support AAV-gene therapy preclinical development for both internal assets and external collaboration. He has a PhD in Microbiology and Molecular Virology from Thomas Jefferson University and a BS in Microbiology from Pennsylvania State University. He completed an academic post-doc at the University of Pennsylvania, under the direction of Dr. Ronald G. Collman.